PharmiWeb13h
Merck Expands Vaccine Production with New State-of-the-Art Facility in North Carolina
Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...
PharmiWeb15h
Herbal Essentials Market Poised for Robust Growth: Industry Analysis, Trends, and Forecast (2024-2034)
The global herbal essentials market is experiencing a significant upsurge, driven by the increasing consumer inclination ...
PharmiWeb15h
Phytoestrogen Supplements Market Forecast: Projected to Reach USD 6.3 Billion by 2034 at 4.7% CAGR- Analysis by TMR
The global phytoestrogen supplements industry is witnessing robust expansion as consumers increasingly shift towards ...
PharmiWeb15h
Cosmetic Lasers Market is expected to achieve a valuation of USD 3.8 billion by 2031, innovations in aesthetic procedures boost market growth | TMR
The global cosmetic lasers market is witnessing significant expansion, driven by the growing demand for minimally invasive ...
PharmiWeb3h
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
ContractHeidelberg Pharma Amends Royalty Financing with HealthCare Royalty 13-March-2025 / 00:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...
PharmiWeb15h
Elsevier launches ScienceDirect AI to transform research with rapid mission-critical insights from trusted content
Elsevier, a global leader in advanced information and decision support, today launches ScienceDirect AI, a cutting-edge generative AI tool for researchers. It is designed to transform the way ...
PharmiWeb11h
ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.i The ...
PharmiWeb13h
Merck Unveils New Facility to Increase Vaccine Production Capacity
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham ...
PharmiWeb11h
Watson-Marlow Fluid Technology Solutions to showcase single-use advancements in sustainability and supply agility at INTERPHEX 2025
Devens, MA, USA, 12th March 2025 / Sciad Communications/ Watson-Marlow Fluid Technology Solutions(WMFTS) will reveal its new WMArchitect Interchangeable Parts service as well as showcase new ...
PharmiWeb15h
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...
PharmiWeb15h
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus ...
PharmiWeb11h
Passing of Genmab A/S’ Annual General Meeting
Genmab A/S (Nasdaq: GMAB) held its Annual General Meeting, today at the Copenhagen Marriott Hotel, Copenhagen, Denmark. At the meeting, Deirdre P. Connelly, Chair of the Board of Directors gave – on ...